Cart
sales@molnova.com
Home - Products - Angiogenesis - CDK - Riviciclib

Riviciclib

CAS No. 920113-03-7

Riviciclib ( P276-00 hydrochloride )

Catalog No. M16603 CAS No. 920113-03-7

A novel potent CDK inhibitor with IC50 of 79 nM, 63 nM and 20 nM for Cdk4/cyclin D1, Cdk1/cyclin B and Cdk9/cyclin T1, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 87 Get Quote
5MG 135 Get Quote
10MG 222 Get Quote
25MG 405 Get Quote
50MG 597 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Riviciclib
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel potent CDK inhibitor with IC50 of 79 nM, 63 nM and 20 nM for Cdk4/cyclin D1, Cdk1/cyclin B and Cdk9/cyclin T1, respectively.
  • Description
    A novel potent CDK inhibitor with IC50 of 79 nM, 63 nM and 20 nM for Cdk4/cyclin D1, Cdk1/cyclin B and Cdk9/cyclin T1, respectively; weakly inhibits Cdk2/cyclin A, Cdk2/cyclin E, Cdk6/cyclin D3 and Cdk7/cyclin H with IC50 of 0.2-3 uM; shows potent antiproliferative effects against various human cancer cell lines (IC50=200-800 nM); induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant in vivo efficacy in tumor models.Pancreatic Cancer Phase 2 Clinical
  • Synonyms
    P276-00 hydrochloride
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    CDK1/CyclinB; CDK2/CyclinA; CDK4/CyclinD1; CDK6/CyclinD3; CDK9/CyclinT1
  • Research Area
    Cancer
  • Indication
    Pancreatic Cancer

Chemical Information

  • CAS Number
    920113-03-7
  • Formula Weight
    438.30
  • Molecular Formula
    C21H20ClNO5.HCl
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN1CCC(C1CO)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O.Cl
  • Chemical Name
    2-(2-chlorophenyl)-5,7-dihydroxy-8-((2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl)-4H-chromen-4-one hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Joshi KS, et al. Mol Cancer Ther. 2007 Mar;6(3):918-25.
2. Joshi KS, et al. Mol Cancer Ther. 2007 Mar;6(3):926-34.
3. Raje N, et al. Leukemia. 2009 May;23(5):961-70.
4. Rathos MJ, et al. J Transl Med. 2012 Aug 8;10:161.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Purvalanol A

    A potent, cell-permeable, selective inhibitor of CDK with IC50s of 4, 70, 35, 850, and 75 nM for cdc2/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E, Cdk4/cyclin D1 and Cdk5-p35, respectively.

  • Mevociclib

    Mevociclib is a highly selective covalent inhibitor of CDK7. SY-1365 possesses therapeutic potential in both hematological and solid tumors.

  • [pThr3]-CDK5 Substra...

    [pThr3]-CDK5 Substrate is an effective Phospho-Thr3CDK5 Substrate.[pThr3]-CDK5 Substrate is phosphorylated by CDK5 with a Km value of 6 μM.

Sign In Join Free